These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 26075501

  • 21. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z, Kong X, Li F, Wei H, Sun R, Tian Z.
    J Immunol; 2013 Oct 15; 191(8):4184-93. PubMed ID: 24048897
    [Abstract] [Full Text] [Related]

  • 22. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y, Chen T, Lu LL, Wang M, Wang D, Yao H, Fan C, Qi J, Zhang Y, Qu C.
    Vaccine; 2017 Feb 15; 35(7):1064-1070. PubMed ID: 28069363
    [Abstract] [Full Text] [Related]

  • 23. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z, Milani S, Sharifi Z.
    Arch Iran Med; 2014 Feb 15; 17(2):106-7. PubMed ID: 24527970
    [Abstract] [Full Text] [Related]

  • 24. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.
    Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S, Lallemant M, Goudeau A, Sirirungsi W, Program for HIV Prevention and Treatment (PHPT-2) group.
    Clin Infect Dis; 2013 Jun 15; 56(12):1704-12. PubMed ID: 23487379
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
    Karimi G, Zadsar M, Vafaei N, Sharifi Z, FalahTafti M.
    Virol J; 2016 Mar 05; 13():36. PubMed ID: 26944046
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J, Ge J, Ren S, Zhou T, Sun Y, Sun H, Gu Y, Huang H, Xu Z, Chen X, Xu X, Zhuang X, Song C, Jia F, Xu A, Yin X, Du SX.
    Vaccine; 2015 Aug 20; 33(35):4247-54. PubMed ID: 25858855
    [Abstract] [Full Text] [Related]

  • 27. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M.
    Antiviral Res; 2012 Oct 20; 96(1):59-64. PubMed ID: 22884884
    [Abstract] [Full Text] [Related]

  • 28. Significance of anti-HBc alone serological status in clinical practice.
    Wang Q, Klenerman P, Semmo N.
    Lancet Gastroenterol Hepatol; 2017 Feb 20; 2(2):123-134. PubMed ID: 28403982
    [Abstract] [Full Text] [Related]

  • 29. Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay.
    Chen C, Jiang X, Liu X, Guo L, Wang W, Gu S, Wen C, Yi X, Tang L, Li Y.
    J Leukoc Biol; 2021 Feb 20; 109(2):455-465. PubMed ID: 32620046
    [Abstract] [Full Text] [Related]

  • 30. Recognition of Core- and Polymerase-derived immunogenic peptides included in novel therapeutic vaccine by T cells from Chinese chronic hepatitis B patients.
    Huang D, Sansas B, Jiang JH, Gong QM, Jin GD, Calais V, Yu DM, Zhu MY, Wei D, Zhang DH, Inchauspé G, Zhang XX, Zhu R.
    J Viral Hepat; 2017 Nov 20; 24 Suppl 1():66-74. PubMed ID: 29082648
    [Abstract] [Full Text] [Related]

  • 31. PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response.
    Petit MA, Capel F, Zoulim F, Dubanchet S, Chemin I, Penna A, Ferrari C, Trépo C.
    Arch Virol Suppl; 1992 Nov 20; 4():105-12. PubMed ID: 1280500
    [Abstract] [Full Text] [Related]

  • 32. Presence of anti-HBc is associated to high rates of HBV resolved infection and low threshold for Occult HBV Infection in HIV patients with negative HBsAg in Chile.
    Vargas JI, Jensen D, Sarmiento V, Peirano F, Acuña P, Fuster F, Soto S, Ahumada R, Huilcaman M, Bruna M, Jensen W, Fuster F.
    J Med Virol; 2016 Apr 20; 88(4):639-46. PubMed ID: 26381185
    [Abstract] [Full Text] [Related]

  • 33. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
    Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S.
    Vaccine; 2011 Aug 26; 29(37):6342-51. PubMed ID: 21600951
    [Abstract] [Full Text] [Related]

  • 34. Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.
    Chen X, Li M, Le X, Ma W, Zhou B.
    Vaccine; 2004 Jan 02; 22(3-4):439-46. PubMed ID: 14670326
    [Abstract] [Full Text] [Related]

  • 35. Re-evaluation of anti-HBc non-reactive serum samples from patients with persistent hepatitis B infection by immune precipitation with labelled HBV core antigen.
    Kantelhardt VC, Schwarz A, Wend U, Schüttler CG, Willems WR, Trimoulet P, Fleury H, Gerlich WH, Kann M.
    J Clin Virol; 2009 Oct 02; 46(2):124-8. PubMed ID: 19631583
    [Abstract] [Full Text] [Related]

  • 36. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma.
    Böcher WO, Herzog-Hauff S, Schlaak J, Meyer zum Büschenfeld KH, Löhr HF.
    Hepatology; 1999 Jan 02; 29(1):238-44. PubMed ID: 9862872
    [Abstract] [Full Text] [Related]

  • 37. [The significance and place of HBsAg neutralization test in the diagnosis and algorithm of hepatitis B infection].
    Aytaç Ö, Toyran A, Aksoy A.
    Mikrobiyol Bul; 2017 Apr 02; 51(2):136-144. PubMed ID: 28566077
    [Abstract] [Full Text] [Related]

  • 38. Isolated hepatitis B core antibody positive among vaccinated cohort in Malaysia.
    Hudu SA, Malik YA, Niazlin MT, Harmal NS, Alshrari AS, Sekawi Z.
    Ann Saudi Med; 2013 Apr 02; 33(6):591-4. PubMed ID: 24413864
    [Abstract] [Full Text] [Related]

  • 39. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X, Ye X, Du P, Zeng J, Zhu W, Yang B, Li C, Allain JP.
    Transfusion; 2015 Apr 02; 55(4):890-7. PubMed ID: 25363504
    [Abstract] [Full Text] [Related]

  • 40. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
    Carotenuto P, Artsen A, Niesters HG, Osterhaus AD, Pontesilli O.
    J Med Virol; 2009 Feb 02; 81(2):332-9. PubMed ID: 19107973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.